Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Immunology

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1100663PMID 22058414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation

  2011cited by this paper
• Cellular mechanisms of TNF function in models of inflammation and autoimmunity.

  2010cited by this paper
• Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs.

  2010cited by this paper
• Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.

  2010cited by this paper
• Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?

  2009influential reference
• Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy.

  2009cited by this paper
• Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected].

  2009cited by this paper
• Corrigendum to “Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NFκB and MAPK dependent pathways in rat astrocytes” [Brain Res. 1287 (2009) 47–57]

  2009cited by this paper
• IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition

  2008cited by this paper
• Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models.

  2008cited by this paper
• Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

  2008cited by this paper
• Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

  2008cited by this paper
• IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.

  2008cited by this paper
• TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity1

  2008cited by this paper
• Loss of blood–brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

  2007cited by this paper
• Paradoxical Anti-Inflammatory Actions of TNF-α: Inhibition of IL-12 and IL-23 via TNF Receptor 1 in Macrophages and Dendritic Cells1

  2005cited by this paper
• Novel tumor necrosis factor‐knockout mice that lack Peyer's patches

  2005cited by this paper
• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

  2005cited by this paper
• Immunology of multiple sclerosis.

  2005cited by this paper
• Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects.

  2005cited by this paper
• Lymphoid Chemokines CCL19 and CCL21 are Expressed in the Central Nervous System During Experimental Autoimmune Encephalomyelitis: Implications for the Maintenance of Chronic Neuroinflammation

  2003influential reference
• Signalling pathways of the TNF superfamily: a double-edged sword

  2003cited by this paper
• Interactions Between Hemopoietically Derived TNF and Central Nervous System-Resident Glial Chemokines Underlie Initiation of Autoimmune Inflammation in the Brain1

  2002cited by this paper
• Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood‐brain barrier suggests their involvement in G‐protein‐dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis

  2002influential reference
• Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors

  2002cited by this paper
• Defective CD4T cell priming and resistance to experimental autoimmune encephalomyelitis in TNF-deficient mice due to innate immune hypo-responsiveness.

  2001cited by this paper
• Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

  2001cited by this paper
• TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

  2001cited by this paper
• Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level

  2001cited by this paper
• CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.

  2001cited by this paper
• Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2)

  2000cited by this paper
• Inhibition of IL-12 Production in Human Monocyte-Derived Macrophages by TNF1

  2000cited by this paper
• Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

  2000cited by this paper
• TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study

  1999cited by this paper
• TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein‐induced experimental autoimmune encephalomyelitis

  1999cited by this paper
• MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.

  1998cited by this paper
• TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination

  1998cited by this paper
• Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting

  1997cited by this paper
• Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).

  1996cited by this paper
• Chemokine expression in murine experimental allergic encephalomyelitis.

  1995cited by this paper
• Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteins

  1994cited by this paper
• Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis

  1993cited by this paper
• Tumour necrosis factor‐alpha synthesis by cerebrospinal‐fluid‐derived T cell clones from patients with multiple sclerosis

  1991cited by this paper
• Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.

  1991cited by this paper
• Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

  1991cited by this paper
• Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

  1990cited by this paper
• An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

  1990cited by this paper
• Tumor necrosis factor identified in multiple sclerosis brain

  1989cited by this paper
• Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies

  1987cited by this paper
• Two types of mouse helper T-cell clone Implications for immune regulation.

  1987cited by this paper
• [Immunology of multiple sclerosis].

  1982cited by this paper
• EncephalomyelitisDuring Experimental Autoimmune Accumulation in the Central Nervous System T Cell + Control of Encephalitogenic CD4 -Inducible Protein-10) g CXCL10 (IFN-and

  year unknowncited by this paper

• Bidirectional Communication Between the Innate and Adaptive Immune Systems

  2025cites this paper
• Human placental stem cells induce a novel multiple myeloid cell-driven immunosuppressive program that ameliorates proinflammatory CNS pathology

  2025influential citation
• Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms

  2024cites this paper
• Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies

  2024cites this paper
• Lymphotoxins from distinct types of lymphoid cells differentially contribute to neuroinflammation

  2024cites this paper
• Unravelling monocyte functions: from the guardians of health to the regulators of disease

  2024cites this paper
• Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers

  2023cites this paper
• Targeting TNFR2 in Cancer: All Roads Lead to Rome

  2022cites this paper
• The dichotomous outcomes of TNFα signaling in CD4+ T cells

  2022cites this paper
• Hesperetin, a Citrus Flavonoid, Ameliorates Inflammatory Cytokine-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation

  2022cites this paper
• TNF hampers intestinal tissue repair in colitis by restricting IL-22 bioavailability

  2022cites this paper
• Targeted Immunotherapy for Autoimmune Disease

  2022cites this paper
• Attenuation of Rheumatoid Arthritis Through the Inhibition of Tumor Necrosis Factor–Induced Caspase 3/Gasdermin E–Mediated Pyroptosis

  2022cites this paper
• Neurological Complications of Biological Treatment of Psoriasis

  2022cites this paper
• Overview of the Effect of Citrobacter rodentium Infection on Host Metabolism and the Microbiota.

  2021cites this paper
• Attenuation of rheumatoid arthritis through the inhibition of caspase3/GSDME-mediated pyroptosis induced by TNF-α.

  2021cites this paper
• Insights into the biology and therapeutic implications of TNF and regulatory T cells

  2021cites this paper
• IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells

  2021cites this paper
• Generation and Evaluation of Bispecific Anti-TNF Antibodies Based on Single-Chain VHH Domains.

  2021cites this paper
• Independent and inter-dependent immunoregulatory effects of NCF1 and NOS2 in experimental autoimmune encephalomyelitis

  2020cites this paper
• Single-Domain Antibodies: Biology, Engineering and Emerging Applications

  2020cites this paper
• Re-Examining the Role of TNF in MS Pathogenesis and Therapy

  2020cites this paper
• Contrasting contributions of TNF from distinct cellular sources in arthritis

  2020cites this paper
• Three-Domain Antibodies against the Tumor Necrosis Factor: Investigation of Their Biological Activity In Vitro

  2020cites this paper
• Quantitative single‐molecule imaging of TNFR1 reveals zafirlukast as antagonist of TNFR1 clustering and TNFα‐induced NF‐ĸB signaling

  2020cites this paper
• 30 Years of Biotherapeutics Development-What Have We Learned?

  2020cites this paper
• Distinct modes of TNF signaling through its two receptors in health and disease

  2020cites this paper
• Tumor Necrosis Factor-α in T Lymphocytes Attenuates Renal Injury and Fibrosis During Nephrotoxic Nephritis.

  2019cites this paper
• Cytokines, reverse genetics and anti-cytokine therapy

  2019cites this paper
• Cytokines, reverse genetics and anti-cytokine therapy

  2019cites this paper
• [Proinflammatory Cytokines and Skin Wound Healing in Mice].

  2019cites this paper
• Proinflammatory Cytokines and Skin Wound Healing in Mice

  2019cites this paper
• The Liver-Stage Plasmodium Infection Is a Critical Checkpoint for Development of Experimental Cerebral Malaria

  2019cites this paper
• Modulation of bioavailability of proinflammatory cytokines produced by myeloid cells.

  2019cites this paper
• T cells instruct myeloid cells to produce inflammasome-independent IL-1β and cause autoimmunity

  2019cites this paper
• Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies

  2018cites this paper
• Cytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis

  2018cites this paper
• Risks associated with use of TNF inhibitors in children with rheumatic diseases

  2018cites this paper
• Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases

  2018cites this paper
• Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity

  2018cites this paper
• Making anti‐cytokine therapy more selective: Studies in mice

  2018cites this paper
• T cells instruct dendritic cells to produce inflammasome independent IL-1β causing systemic inflammation

  2018cites this paper
• Bispecific Antibodies: Formats and Areas of Application

  2018cites this paper
• Comparative Study of the Influence of Iem-1556 and Glatiramer Acetate (Copaxon) on the Severity of Neurologic Disorders and the Duration of Experimental Allergic Encephalomielitis in the Rats

  2018cites this paper
• A New Venue of TNF Targeting

  2018influential citation
• CNS Demyelination with TNF-α Blockers

  2017cites this paper
• [Cytokine neutralization at specific cellular source : A new therapeutic paradigm? German Version].

  2017cites this paper
• TNFR1 inhibition with a Nanobody protects against EAE development in mice

  2017cites this paper
• Can we design a better anti‐cytokine therapy?

  2017cites this paper
• Experimental Autoimmune Encephalomyelitis Ameliorated by Passive Transfer of Polymerase 1-Silenced MOG35-55 Lymphatic Node Cells: Verification of a Novel Therapeutic Approach in Multiple Sclerosis

  2017influential citation
• VHH-Based Bispecific Antibodies Targeting Cytokine Production

  2017cites this paper
• Zytokinneutralisierung an spezifischen zellulären Quellen

  2017cites this paper
• Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation

  2017cites this paper
• Myeloid and T Cell-Derived TNF Protects against Central Nervous System Tuberculosis

  2017cites this paper
• A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis

  2016cites this paper
• Cytokine neutralization at specific cellular source

  2016cites this paper
• Mechanisms of Blood–Brain Barrier Disintegration in the Pathophysiology of Multiple Sclerosis

  2016cites this paper
• Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns

  2016cites this paper
• The role of interleukin-6 signaling in nervous tissue.

  2016influential citation
• Cell-type–restricted anti-cytokine therapy: TNF inhibition from one pathogenic source

  2016cites this paper
• Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis

  2016cites this paper
• Bruton’s tyrosine kinase in chronic inflammation: from pathophysiology to therapy

  2015cites this paper
• Tumor Necrosis Factor Alpha Converting Enzyme Inhibition during Acute Colitis in Mice: A Regional Analysis

  2015cites this paper
• Regulation of Anti-viral Immunity by Dendritic Cells and Natural Killer Cells

  2015cites this paper
• Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis

  2015cites this paper
• Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study

  2014cites this paper
• Blockade of tumour necrosis factor‐α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen‐specific immune response and central nervous system histopathology

  2014cites this paper
• MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination

  2014cites this paper
• TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities.

  2014cites this paper
• Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice.

  2014cites this paper
• Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats

  2014cites this paper
• Dynamic changes in chromatin conformation at the TNF transcription start site in T helper lymphocyte subsets

  2014cites this paper
• Regulation of Adaptive Immunity by the Fractalkine Receptor during Autoimmune Inflammation

  2013cites this paper
• The cytokine networks of adaptive immunity in fish.

  2013cites this paper
• TNF-Alpha Antagonists and Neurologic Side Effects: A Literature Review

  2013cites this paper
• This information is current as Inflammation Fractalkine Receptor during Autoimmune Regulation of Adaptive Immunity by the

  2013cites this paper
• Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: Beneficial effects in experimental autoimmune encephalomyelitis

  2013cites this paper
• Immunophenotypical and functional characterization of CD 56 bright NK cells in multiple sclerosis

  2012cites this paper
• Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages

  2012cites this paper